Sunday, January 09, 2022 1:02:09 PM
We have a small number of guys who had a helluva task ahead of them last month. Two FDA meetings, as well as one with MHRA. At least two additional trials they are also trying to progress.
So yes, a PR with inaccurate information. But, information we will be able to access tomorrow. Before the market opens.
You know you've found a winner when you meet the primary endpoint of a clinical trial of the only drug designed to prevent and treat Covid in hospitalized and hypoxic patients. And Intellectual Property rights aren't awarded to amateurs.
Green Leaf Innovations, Inc. Engages Olayinka Oyebola & Co for Two-Year Audit • GRLF • May 28, 2024 8:30 AM
HealthLynked Introduces AI-Powered Chat Function to Enhance Healthcare Accessibility • HLYK • May 28, 2024 8:00 AM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM